Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Extensive preclinical and clinical data on moxifloxacin presented at ICAAC

Oct. 14, 1997

New results reported for Glaxo Wellcome's anti-HCMV agent at ICAAC

Oct. 14, 1997

GM-237354: a new antifungal sordarin derivative from Glaxo Wellcome

Oct. 13, 1997

Renal effects of NO donor FK-409 in dogs

Oct. 10, 1997

Selective iNOS inhibitor inhibits tumor growth in mice

Oct. 10, 1997

Spotlight on angiotensin II blocker/ACE inhibitor combination therapy

Oct. 10, 1997

Significant research efforts center on new ketolide at Hoechst Marion Roussel

Oct. 9, 1997

Novel amphotericin B formulation reported by Japanese academics

Oct. 8, 1997

SB-207499: a second-generation PDE IV inhibitor from SmithKline Beecham

Oct. 8, 1997

NTZ: a potential new anti-H. pylori agent

Oct. 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...